NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Winston-Salem-based Plakous Therapeutics has won the 2022 NC BIONEER Venture Challenge. The announcement was made at Triad BioNight.
Here are the winners of Excellence Awards at Triad BioNight, a celebration of the region’s life sciences community organized by the Piedmont Triad Office of the North Carolina Biotechnology Center.
Durham-based Precision Biosciences’ genome editing technology has drawn interest – and investment – from another global pharmaceutical giant. This time it’s Novartis.
Guy Aday was the operations chief for the U.S. Consulate in Northern Afghanistan. After he injured his back and returned to the U.S. for back surgery and physical and vocational rehabilitation, he found a rewarding new career path in biotech via Alamance Community College.
Novozymes and Biotalys are partnering on developing the market for Biotalys’ new environmentally friendly biofungicide, Evoca,
The Foundation Fighting Blindness (FFB), with a spinoff startup headquartered in the Raleigh, is changing its executive leadership team.
The North Carolina Biotechnology Center awarded 18 grants and loans totaling $1,755,181 to universities, bioscience companies and nonprofit organizations in the third quarter of its fiscal year.
Five North Carolina startups are headed to High Point University this week to compete in the Venture Pitch Showcase with the goal of being named the North Carolina Biotechnology Center’s NC BIONEER Venture Challenge winner.
Novozymes and AgroFresh have announced a collaboration in which they'll be working together to find sustainable solutions that keep foods fresher, longer, after harvest and reduce product loss.
Following two years of development, Astellas’ new late-stage clinical and commercial manufacturing plant officially opened its doors in Sanford.
The White House is closely reviewing North Carolina’s COVID response to glean “best practice” for pandemic preparedness going forward.
A drug produced by BioCryst Pharmaceuticals of Durham has won regulatory approval in Canada and Switzerland for preventing hereditary angioedema (HAE), a rare disease of swollen tissues caused by excessive fluid buildup.
Two whopping life sciences “gets” helped put North Carolina in a special award status in the current issue of Area Development, a quarterly publication covering site selection, facility planning, and economic development.
Biotalys’ new biofungicide Evoca has received the World BioProtection Award for Best Biofungicide.
Wilmington-based Renaissance Fiber will represent the state’s southeastern region at the North Carolina Biotechnology Center’s Venture Pitch Showcase at Triad BioNight in High Point next month.
scroll back to top of page